Significance of CD47 expression in gastric cancer

Tomoya Sudo, Yusuke Takahashi, Genta Sawada, Ryutaro Uchi, Koshi Mimori, Yoshito Akagi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Integrin-associated protein (CD47) is ubiquitously expressed on the surface of cells and functions as an identi-fier of self. In blood cancer, tumor cells expressing CD47 evade phagocytosis by macrophages, leading to a poor patient prognosis. However, the status of CD47 expression in solid tumors, particularly in gastric cancer, is not well understood. The purpose of the present study was to examine the level of CD47 in the primary tumor, peripheral blood (PB) and bone marrow (BM) of patients with gastric cancer, and to deter-mine its effect. Reverse transcription-quantitative polymerase chain reaction analysis was performed to determine the level of CD47 mRNA expression in primary tumor, PB and BM samples collected from 168 patients with gastric cancer. Cell sorting was performed to investigate CD47 protein expression in PB and BM fractions, and to identify the source of CD47 expression. In primary tumors, the expression of CD47 was not associated with any clinicopathological factors or prognosis. By contrast, in PB, the low CD47 expression group demonstrated a significantly increased tumor size, and frequency of lymphatic invasion and lymph node metastasis, compared with the high CD47 expression group. In addition, the clinical tumor stage of the low CD47 expression group was significantly increased compared with that of the high CD47 expression group. Conversely, in PB, the high CD47 expression group had a significantly higher frequency of lymphatic invasion and lymph node metastasis compared with the low CD47 expression group. The lymphocyte fraction exhibited the highest CD47 expres-sion compared with the other fractions in PB and BM samples. Low expression of CD47 was associated with the advancement of gastric cancer, in contrast to other cancers, and it may be associated with a decrease in lymphocytes during later stages. These results indicate that CD47 expression in the PB and BM may serve as a marker to analyze the immunological function of patients with gastric cancer; however, the significance of CD47 in gastric cancer requires further study.

Original languageEnglish
Pages (from-to)801-809
Number of pages9
JournalOncology Letters
Volume14
Issue number1
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Stomach Neoplasms
Bone Marrow
Neoplasms
Lymph Nodes
Lymphocytes
Neoplasm Metastasis
Phagocytosis
Integrins
Reverse Transcription
Proteins
Macrophages
Polymerase Chain Reaction
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Sudo, T., Takahashi, Y., Sawada, G., Uchi, R., Mimori, K., & Akagi, Y. (2017). Significance of CD47 expression in gastric cancer. Oncology Letters, 14(1), 801-809. https://doi.org/10.3892/ol.2017.6257

Significance of CD47 expression in gastric cancer. / Sudo, Tomoya; Takahashi, Yusuke; Sawada, Genta; Uchi, Ryutaro; Mimori, Koshi; Akagi, Yoshito.

In: Oncology Letters, Vol. 14, No. 1, 01.01.2017, p. 801-809.

Research output: Contribution to journalArticle

Sudo, T, Takahashi, Y, Sawada, G, Uchi, R, Mimori, K & Akagi, Y 2017, 'Significance of CD47 expression in gastric cancer', Oncology Letters, vol. 14, no. 1, pp. 801-809. https://doi.org/10.3892/ol.2017.6257
Sudo T, Takahashi Y, Sawada G, Uchi R, Mimori K, Akagi Y. Significance of CD47 expression in gastric cancer. Oncology Letters. 2017 Jan 1;14(1):801-809. https://doi.org/10.3892/ol.2017.6257
Sudo, Tomoya ; Takahashi, Yusuke ; Sawada, Genta ; Uchi, Ryutaro ; Mimori, Koshi ; Akagi, Yoshito. / Significance of CD47 expression in gastric cancer. In: Oncology Letters. 2017 ; Vol. 14, No. 1. pp. 801-809.
@article{983ec5b5938946359b5115a578853aff,
title = "Significance of CD47 expression in gastric cancer",
abstract = "Integrin-associated protein (CD47) is ubiquitously expressed on the surface of cells and functions as an identi-fier of self. In blood cancer, tumor cells expressing CD47 evade phagocytosis by macrophages, leading to a poor patient prognosis. However, the status of CD47 expression in solid tumors, particularly in gastric cancer, is not well understood. The purpose of the present study was to examine the level of CD47 in the primary tumor, peripheral blood (PB) and bone marrow (BM) of patients with gastric cancer, and to deter-mine its effect. Reverse transcription-quantitative polymerase chain reaction analysis was performed to determine the level of CD47 mRNA expression in primary tumor, PB and BM samples collected from 168 patients with gastric cancer. Cell sorting was performed to investigate CD47 protein expression in PB and BM fractions, and to identify the source of CD47 expression. In primary tumors, the expression of CD47 was not associated with any clinicopathological factors or prognosis. By contrast, in PB, the low CD47 expression group demonstrated a significantly increased tumor size, and frequency of lymphatic invasion and lymph node metastasis, compared with the high CD47 expression group. In addition, the clinical tumor stage of the low CD47 expression group was significantly increased compared with that of the high CD47 expression group. Conversely, in PB, the high CD47 expression group had a significantly higher frequency of lymphatic invasion and lymph node metastasis compared with the low CD47 expression group. The lymphocyte fraction exhibited the highest CD47 expres-sion compared with the other fractions in PB and BM samples. Low expression of CD47 was associated with the advancement of gastric cancer, in contrast to other cancers, and it may be associated with a decrease in lymphocytes during later stages. These results indicate that CD47 expression in the PB and BM may serve as a marker to analyze the immunological function of patients with gastric cancer; however, the significance of CD47 in gastric cancer requires further study.",
author = "Tomoya Sudo and Yusuke Takahashi and Genta Sawada and Ryutaro Uchi and Koshi Mimori and Yoshito Akagi",
year = "2017",
month = "1",
day = "1",
doi = "10.3892/ol.2017.6257",
language = "English",
volume = "14",
pages = "801--809",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Significance of CD47 expression in gastric cancer

AU - Sudo, Tomoya

AU - Takahashi, Yusuke

AU - Sawada, Genta

AU - Uchi, Ryutaro

AU - Mimori, Koshi

AU - Akagi, Yoshito

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Integrin-associated protein (CD47) is ubiquitously expressed on the surface of cells and functions as an identi-fier of self. In blood cancer, tumor cells expressing CD47 evade phagocytosis by macrophages, leading to a poor patient prognosis. However, the status of CD47 expression in solid tumors, particularly in gastric cancer, is not well understood. The purpose of the present study was to examine the level of CD47 in the primary tumor, peripheral blood (PB) and bone marrow (BM) of patients with gastric cancer, and to deter-mine its effect. Reverse transcription-quantitative polymerase chain reaction analysis was performed to determine the level of CD47 mRNA expression in primary tumor, PB and BM samples collected from 168 patients with gastric cancer. Cell sorting was performed to investigate CD47 protein expression in PB and BM fractions, and to identify the source of CD47 expression. In primary tumors, the expression of CD47 was not associated with any clinicopathological factors or prognosis. By contrast, in PB, the low CD47 expression group demonstrated a significantly increased tumor size, and frequency of lymphatic invasion and lymph node metastasis, compared with the high CD47 expression group. In addition, the clinical tumor stage of the low CD47 expression group was significantly increased compared with that of the high CD47 expression group. Conversely, in PB, the high CD47 expression group had a significantly higher frequency of lymphatic invasion and lymph node metastasis compared with the low CD47 expression group. The lymphocyte fraction exhibited the highest CD47 expres-sion compared with the other fractions in PB and BM samples. Low expression of CD47 was associated with the advancement of gastric cancer, in contrast to other cancers, and it may be associated with a decrease in lymphocytes during later stages. These results indicate that CD47 expression in the PB and BM may serve as a marker to analyze the immunological function of patients with gastric cancer; however, the significance of CD47 in gastric cancer requires further study.

AB - Integrin-associated protein (CD47) is ubiquitously expressed on the surface of cells and functions as an identi-fier of self. In blood cancer, tumor cells expressing CD47 evade phagocytosis by macrophages, leading to a poor patient prognosis. However, the status of CD47 expression in solid tumors, particularly in gastric cancer, is not well understood. The purpose of the present study was to examine the level of CD47 in the primary tumor, peripheral blood (PB) and bone marrow (BM) of patients with gastric cancer, and to deter-mine its effect. Reverse transcription-quantitative polymerase chain reaction analysis was performed to determine the level of CD47 mRNA expression in primary tumor, PB and BM samples collected from 168 patients with gastric cancer. Cell sorting was performed to investigate CD47 protein expression in PB and BM fractions, and to identify the source of CD47 expression. In primary tumors, the expression of CD47 was not associated with any clinicopathological factors or prognosis. By contrast, in PB, the low CD47 expression group demonstrated a significantly increased tumor size, and frequency of lymphatic invasion and lymph node metastasis, compared with the high CD47 expression group. In addition, the clinical tumor stage of the low CD47 expression group was significantly increased compared with that of the high CD47 expression group. Conversely, in PB, the high CD47 expression group had a significantly higher frequency of lymphatic invasion and lymph node metastasis compared with the low CD47 expression group. The lymphocyte fraction exhibited the highest CD47 expres-sion compared with the other fractions in PB and BM samples. Low expression of CD47 was associated with the advancement of gastric cancer, in contrast to other cancers, and it may be associated with a decrease in lymphocytes during later stages. These results indicate that CD47 expression in the PB and BM may serve as a marker to analyze the immunological function of patients with gastric cancer; however, the significance of CD47 in gastric cancer requires further study.

UR - http://www.scopus.com/inward/record.url?scp=85020219401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020219401&partnerID=8YFLogxK

U2 - 10.3892/ol.2017.6257

DO - 10.3892/ol.2017.6257

M3 - Article

VL - 14

SP - 801

EP - 809

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 1

ER -